These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26110202)

  • 1. Relative percentage signal intensity recovery of perfusion metrics—an efficient tool for differentiating grades of glioma.
    Smitha KA; Gupta AK; Jayasree RS
    Br J Radiol; 2015 Aug; 88(1052):20140784. PubMed ID: 26110202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain.
    Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A
    Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
    Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
    Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project.
    Direksunthorn T; Chawalparit O; Sangruchi T; Witthiwej T; Tritrakarn SO; Piyapittayanan S; Charnchaowanish P; Pornpunyawut P; Sathornsumetee S
    J Med Assoc Thai; 2013 Sep; 96(9):1183-90. PubMed ID: 24163995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional arterial spin labeling imaging and dynamic susceptibility contrast perfusion-weighted imaging value in diagnosing glioma grade prior to surgery.
    Ma H; Wang Z; Xu K; Shao Z; Yang C; Xu P; Liu X; Hu C; Lu X; Rong Y
    Exp Ther Med; 2017 Jun; 13(6):2691-2698. PubMed ID: 28587332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas.
    Rau MK; Braun C; Skardelly M; Schittenhelm J; Paulsen F; Bender B; Ernemann U; Bisdas S
    J Neurooncol; 2014 Dec; 120(3):557-66. PubMed ID: 25154323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
    Fayed N; Dávila J; Medrano J; Olmos S
    Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data-driven grading of brain gliomas: a multiparametric MR imaging study.
    Caulo M; Panara V; Tortora D; Mattei PA; Briganti C; Pravatà E; Salice S; Cotroneo AR; Tartaro A
    Radiology; 2014 Aug; 272(2):494-503. PubMed ID: 24661247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Different Post-Processing Algorithms for Dynamic Susceptibility Contrast Perfusion Imaging of Cerebral Gliomas.
    Kudo K; Uwano I; Hirai T; Murakami R; Nakamura H; Fujima N; Yamashita F; Goodwin J; Higuchi S; Sasaki M
    Magn Reson Med Sci; 2017 Apr; 16(2):129-136. PubMed ID: 27646457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective glioma grading using single-dose dynamic contrast-enhanced perfusion MRI.
    Jain KK; Sahoo P; Tyagi R; Mehta A; Patir R; Vaishya S; Prakash N; Vasudev N; Gupta RK
    Clin Radiol; 2015 Oct; 70(10):1128-35. PubMed ID: 26152879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Perfusion magnetic resonance imaging for high grade astrocytomas: Can cerebral blood volume, peak height, and percentage of signal intensity recovery distinguish between progression and pseudoprogression?].
    Martínez-Martínez A; Martínez-Bosch J
    Radiologia; 2014; 56(1):35-43. PubMed ID: 23790618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.
    Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M
    Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.